Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy

被引：22

作者：

Graafland, Niels M. ^{[1
,2
]}

Szabados, Bernadett ^{[3
]}

Tanabalan, Chandran ^{[4
]}

Kuusk, Teele ^{[5
]}

Mumtaz, Faiz ^{[5
]}

Barod, Ravi ^{[5
]}

Nicol, David ^{[4
]}

Boleti, Ekaterini ^{[5
]}

Powles, Tom ^{[3
,5
]}

Haanen, John B. ^{[6
]}

Bex, Axel ^{[1
,2
,5
,7
]}

机构：

[1] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands

[2] Renal Canc Network, Amsterdam, Netherlands

[3] Barts Canc Ctr, Dept Med Oncol, London, England

[4] Royal Marsden Hosp, Dept Urol, London, England

[5] Royal Free London NHS Fdn Trust, Specialist Ctr Kidney Canc, London, England

[6] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[7] UCL, Div Surg & Intervent Sci, London, England

来源：

EUROPEAN UROLOGY ONCOLOGY | 2022年 / 5卷 / 03期

关键词：

D O I：

10.1016/j.euo.2021.11.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：373 / 374

页数：2

共 5 条

[1] Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma [J].

Albiges, Laurence ;

Powles, Tom ;

Staehlerr, Michael ;

Bensalan, Karim ;

Giles, Rachel H. ;

Hora, Milan ;

Kuczyk, Markus A. ;

Lam, Thomas B. ;

Ljungberg, Brje ;

Marconi, Lorenzo ;

Merseburger, Axel S. ;

Volpe, Alessandro ;

Abu-Ghanem, Yasmin ;

Dabestani, Saeed ;

Fernandez-Pello, Sergio ;

Hofmann, Fabian ;

Kuusk, Teele ;

Tahbaz, Rana ;

Bex, Axel .

EUROPEAN UROLOGY, 2019, 76 (02) :151-156

[2] Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? [J].

Pignot, Geraldine ;

Thiery-Vuillemin, Antoine ;

Walz, Jochen ;

Lang, Herve ;

Werle, Pierre ;

Balssa, Lac ;

Geoffrois, Lionnel ;

Leblanc, Louis ;

Albiges, Laurence ;

di Nunno, Vincenzo ;

Bensalah, Karim ;

Ladoire, Sylvain ;

Gravis, Gwenaelle ;

Barthelemy, Philippe .

EUROPEAN UROLOGY, 2020, 77 (06) :761-763

[3] Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma [J].

Roussel, Eduard ;

Campi, Riccardo ;

Larcher, Alessandro ;

Verbiest, Annelies ;

Antonelli, Alessandro ;

Palumbo, Carlotta ;

Derweesh, Ithaar ;

Ghali, Fady ;

Bradshaw, Aaron ;

Meagher, Margaret F. ;

Heck, Matthias ;

Amiel, Thomas ;

Kriegmair, Maximilian C. ;

Rubio, Jose ;

Musquera, Mireia ;

D'Anna, Maurizio ;

Autorino, Riccardo ;

Guruli, Georgi ;

Veccia, Alessandro ;

Linares-Espinos, Estefania ;

Van Bruwaene, Siska ;

Hevia, Vital ;

Porpiglia, Francesco ;

Checcucci, Enrico ;

Minervini, Andrea ;

Mari, Andrea ;

Pavan, Nicola ;

Claps, Francesco ;

Marchioni, Michele ;

Capitanio, Umberto ;

Beuselinck, Benoit ;

Mir, Maria C. ;

Albersen, Maarten .

EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (04) :523-529

[4] Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma [J].

Singla, Nirmish ;

Elias, Roy ;

Ghandour, Rashed A. ;

Freifeld, Yuval ;

Bowman, Isaac A. ;

Rapoport, Leonid ;

Enikeev, Mikhail ;

Lohrey, Jay ;

Woldu, Solomon L. ;

Gahan, Jeffrey C. ;

Bagrodia, Aditya ;

Brugarolas, James ;

Hammers, Hans J. ;

Margulis, Vitaly .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (12) :924-931

[5] Thirty-month follow-up of the phase III CheckMate 214 trial of first-line nivolumab plus ipilimumab (N plus I) or sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC). [J].

Tannir, Nizar M. ;

Frontera, Osvaldo Aren ;

Hammers, Hans J. ;

Carducci, Michael Anthony ;

McDermott, David F. ;

Salman, Pamela ;

Escudier, Bernard ;

Beuselinck, Benoit ;

Amin, Asim ;

Porta, Camillo ;

George, Saby ;

Bracarda, Sergio ;

Tykodi, Scott S. ;

Powles, Thomas ;

Rini, Brian I. ;

Tomita, Yoshihiko ;

McHenry, M. Brent ;

Mekan, Sabeen Fatima ;

Motzer, Robert J. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)

← 1 →